Clinical Trial

Respiratory infections


Start:  01 September 2019

End:  31 August 2022


Clinical trial, phase IV, randomized, double-blind, controlled, in children aged 12 to 35 months, of the vaccine against seasonal influenza to estimate efficacy against influenza and other respiratory infections.

Main objective of the trial

To estimate the effectiveness of the inactivated flu vaccine with the number of episodes of acute respiratory infections, its severity and its complications in children with risk.

More information